Jul 15 |
AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
|
Jul 15 |
AbbVie (ABBV) Files for Rinvoq in Giant Cell Arteritis in US & EU
|
Jul 15 |
Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 75% Return On Equity?
|
Jul 14 |
3 Dividend Growth Stocks to Buy and Hold
|
Jul 14 |
3 High-Yield Dividend Stocks That Still Look Like Bargains
|
Jul 12 |
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
|
Jul 12 |
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis
|
Jul 11 |
AbbVie (ABBV) Gains As Market Dips: What You Should Know
|
Jul 11 |
AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
|
Jul 11 |
Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend
|